• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>IsoRay

IsoRay

  1. MOLOGEN AG: First patients enrolled in extension phase of the HIV study TEACH

    MOLOGEN AG: First patients enrolled in extension phase of the HIV study TEACH

  2. MOLOGEN Completes Portfolio Review: Shift from Research to Product- and Market-Oriented Company

    MOLOGEN Completes Portfolio Review: Shift from Research to Product- and Market-Oriented Company

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.